Company Filing History:
Years Active: 2025
Title: Olivier Laloux: Innovator in Controlled-Release Microparticle Technology
Introduction
Olivier Laloux is a notable inventor based in Court-Saint-Etienne, Belgium. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of controlled-release microparticles. His innovative work aims to enhance the delivery of pharmaceutically active compounds.
Latest Patents
Laloux holds a patent for "Multilayered pharmaceutically active compound-releasing microparticles in a liquid dosage form." This invention involves a controlled-release multilayer microparticle designed for oral administration or direct administration in the stomach. The microparticle consists of a core that includes the pharmaceutically active compound, which may be pramipexole, a controlled-release intermediate coating layer, and an outer protection coating layer. The external protection layer is composed of a hydrophilic gastro-soluble component and a hydrophobic or insoluble component. Additionally, the patent covers a liquid pharmaceutical composition containing these microparticles, a kit for preparing the liquid composition, and methods for treating diseases with the composition.
Career Highlights
Olivier Laloux is associated with Be Pharbel Manufacturing, where he continues to innovate in the pharmaceutical sector. His work focuses on improving drug delivery systems, which can significantly impact patient treatment outcomes.
Collaborations
Laloux collaborates with talented professionals in his field, including Geoffrey De Bilde and Pierre Sacre. Their combined expertise contributes to the advancement of pharmaceutical technologies.
Conclusion
Olivier Laloux's contributions to controlled-release microparticle technology represent a significant advancement in pharmaceutical science. His innovative patent and ongoing work at Be Pharbel Manufacturing highlight his commitment to improving drug delivery systems.